Publications by the researcher in collaboration with Carmen Guadalupe Rodríguez González (12)

2022

  1. Implementation and evaluation of a home pharmaceutical care model through Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 36-46

2021

  1. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 2

  2. Error detection and cost savings with an image-based workflow management system connected to a computerized prescription order entry program for antineoplastic compounding

    Journal of Patient Safety, Vol. 17, Núm. 8, pp. E1589-E1594

2020

  1. Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 299-301

  2. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

    Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010

2019

  1. Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

    Applied Clinical Informatics, Vol. 10, Núm. 3, pp. 513-520

  2. Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy

    Journal of Evaluation in Clinical Practice, Vol. 25, Núm. 1, pp. 28-35

2018

  1. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

    Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

2016

  1. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908

2013

  1. Equipotent doses of pegylated epoetin β (CERA) for the treatment of outcome patients with anemia secondary to chronic kidney disease in clinical practice

    Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 55-58

  2. Permanencia del tratamiento antirretroviral de última generación en la práctica clínica diaria

    Farmacia Hospitalaria, Vol. 37, Núm. 2, pp. 151-155